Navigation Links
Oxford Finance Provides $3 Million Growth Capital Loan to Avantis Medical Systems
Date:11/9/2011

s, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $1.5 billion in loans, with lines of credit ranging from $500 thousand to $50 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Illinois, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.  

About the Third Eye Retroscope and Avantis Medical Systems, Inc.

Avantis Medical Systems, Inc. markets the Third Eye® Retroscope®, an FDA-cleared, disposable, catheter-based camera indicated for use with a standard colonoscope to provide an additional view of the colon for diagnostic purposes.  It is inserted through the instrument channel of a standard colonoscope to provide the physician with a retrograde (backward) view of the lining of the colon.  Avantis Medical is focused on delivering cost-effective solutions for improved detection and prevention of cancers of the gastrointestinal tract.  For more information, visit www.AvantisMedical.com or www.ThirdEyeRetroscope.com.

(I)  DeMarco DC, Odstrcil E, Lara LF, et al. Impact of Experience with a Retrograde-Viewing Device on Adenoma Detection Rates and Withdrawal Times during Colonoscopy: The Third Eye Retroscope Study Group. Gastrointest Endosc 2010;71:542-50

(II)  Leufkens AM, Demarco DC, Siersema PD, et al. Effect of a Retrograde-Viewing Device on Adenoma Detection Rate during Colonoscopy: The "TERRACE" Study. Gastrointest Endosc 2011;73:480-90

(III) Siersema P, Rastogi A, Leufkens A, et al. A Retrograde-Viewing Device Improves Adenoma Detection Rate in Colonoscopies for Surveillance and Diagnostic Workup. Am J Gastroenterol 2011; 106: S537-8.
'/>"/>

SOURCE Oxford Finance LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. UK Chalks Up $253 Million in Investment in Q2 2011: Oxford Cluster Takes the Largest Bite of the Apple
2. Oxford BioMedica Announces Ocular Programme Update
3. Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp.
4. Oxford BioTherapeutics Licenses BioWas POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer
5. ICAP Ocean Tomo Announces Four Patent Sets From Oxford Instruments - Each Represents an Important Advancement in Technology
6. Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation
7. Oxford Finance Corporation Hires Debbie Baker to Support Life Science Business Development in Western North America
8. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
9. Oxford Finance Corporation and United Orthopedic Group, Inc. Close $20 Million Credit Facility
10. Oxford Finance Corporation Facilitates Entry for Reata Pharmaceuticals into Asian Markets
11. Oxford Finance Corporation Closes $25 Million Credit Facility with EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Cynosure, Inc. (Nasdaq: CYNO ), which ... procedures and precision surgical applications worldwide, today reported ... 30, 2015. "Our North American business ... increased 47 percent year-over-year and selling prices remained ... "While our international results reflected the economic slowdowns ...
(Date:7/28/2015)... Baebies, Inc. today announced the completion of ... oversubscribed round of financing included key investors Rex Health ... Capital, Triad, LLC, the Duke Angel Network and a ... Advanced Liquid Logic,s (ALL) former investors including Charleston Angel ... "Rex is pleased to support this promising young ...
(Date:7/28/2015)... 28, 2015  CryoLife, Inc. (NYSE: CRY ), ... on cardiac and vascular surgery, announced today its results ... 2015.  Pat Mackin, Chairman, President and ... to execute on our growth strategy with solid progress ... we announced plans to transition to a direct sales ...
Breaking Medicine Technology:Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 2Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 5Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 6Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 7Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 8Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 9Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 10Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 11Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 12Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 13Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14
... , , , PARSIPPANY, N.J., Jan. 11 ... pharmaceutical industry your survival depends on not only what you ... Pharma market research is key. Whoever has the right ... U.S. pharmaceutical industry is the largest (and growing) market in ...
... , ... Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP ... clinical trial of a prototype formulation of its proprietary delayed-release cysteamine ... M.D., Professor of Pediatrics at the University of California, San Diego, ...
Cached Medicine Technology:Elite Pharma Insiders to Reveal Key Survival Strategies for Pharmaceutical Industry in 2010 2Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis 2Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis 3Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis 4Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis 5Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis 6Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis 7
(Date:7/28/2015)... , ... July 29, 2015 , ... ... executives, doctors, lawyers and other A-Listers, has evolved into a world class millionaires ... a Millionaire strives to match successful and attractive people seeking real, meaningful and ...
(Date:7/28/2015)... ... July 29, 2015 , ... City Sports, a specialty ... announced veteran retail executive Marty Hanaka as CEO. , Hanaka, who has served on ... as an operating partner at the Highland Consumer Fund has had previous tenures as ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... have received the Get With The Guidelines®-Stroke Gold Plus Award for implementing specific ... care and outcomes. , The Get With The Guidelines-Stroke program recognizes hospitals ...
(Date:7/28/2015)... Meadows, Ill. (PRWEB) , ... July 28, 2015 , ... ... been commended with a national 2015 Power of A award for “helping to make ... a Power of A Gold Award winner by the American Society of Association Executives. ...
(Date:7/28/2015)... ... July 28, 2015 , ... The Triumph Modular, Redefining ... consumer education, resource library, floor plans, educational blog and wide use of imagery. ... regular posts with valuable links to useful reports by industry experts. Comments are ...
Breaking Medicine News(10 mins):Health News:Meet a Millionaire Announces It’s Not a Sugar Daddy Site, It’s a True Millionaires Club 2Health News:City Sports Names Marty Hanaka CEO 2Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 2Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 3Health News:ASDS Skin Cancer Program Honored 2Health News:ASDS Skin Cancer Program Honored 3Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2
... Revenue Tops $45 Million Reflecting 79% Growth Over Prior ... Revises 2007 Guidance and Reaffirms 2008 Guidance, COEUR ... NHWK ), the leading provider of radiology,solutions to ... for its third quarter ended September 30, 2007. Revenue,grew ...
... ROCKVILLE, Md., Oct. 30 Vanda Pharmaceuticals,Inc. (Nasdaq: ... the development,and commercialization of clinical-stage product candidates for ... the,Company,s Proof- of-Concept Phase II clinical trial evaluating ... This Phase II study examined the effects of ...
... YORK, Oct. 30 Florida already allows it. And ... pharmacists the,authority to independently prescribe prescription drugs, a move ... billion in 2006 to,$145 billion by 2012, according to ... Kalorama Information. The study shows that 77% of ...
... On Sunday, November 4,2007, Eli Lilly and Company ... with,the investment community and media to review the details ... Association,Scientific Sessions in Orlando, Florida. This call will follow ... TRITON TIMI-38 trial. The Lilly conference call will ...
... called retinoic acid was associated with reduced lung cell growth ... study published online October 30 in the Journal of ... at elevated risk for lung cancer. According to one hypothesis, ... continue to grow and evolve into cancer even after that ...
... Oct. 30 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ... and,medical device company, is scheduled to participate in ... held November 5 - 7 in New York ... will make a 30-minute,presentation followed by a 30-minute ...
Cached Medicine News:Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 2Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 3Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 4Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 5Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 6Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 7Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 8Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 9Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 10Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 11Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 12Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 13Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 14Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 15Health News:NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results 16Health News:Vanda Pharmaceuticals' VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties 2Health News:Vanda Pharmaceuticals' VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties 3Health News:Vanda Pharmaceuticals' VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties 4Health News:By 2012, Prescribing Pharmacists Could Influence $145 Billion in Drug Sales 2Health News:Vitamin A derivative associated with reduced growth in some lung cells 2
Pilot and control your analysis at a touch. 26 parameters CBC/DIFF with autoloader...
... The VARIANT™ Total GHb ... from non-glycated hemoglobin regardless ... interference from Schiff Base. ... to the DCCT reference ...
A 3080/3085 orthopedic extension serves as a mobile, radiolucent orthopedic platform. When not in use, accessories can be removed and stored in cart....
... Pulsavac Wound Debridement System ... for pulsatile irrigation,and debridement. ... range of fluid pressure ... lavage to a penetrating ...
Medicine Products: